For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240205:nRSE9417Ba&default-theme=true
RNS Number : 9417B Kosmos Energy Limited 05 February 2024
Kosmos Energy Ltd (the "Company")
PDMR Shareholding
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE
EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITIES
05 February 2024
The following Persons Discharging Managerial Responsibilities ("PDMRs") have
had changes in their shareholdings of Common Stock in the Company:
PDMR Date of transaction No. of shares vested No. of shares granted No. of shares sold or withheld
Christopher J. Ball 31 January 2024 493,000 99,525 0
Christopher J. Ball 1 February 2024 0 0 114,423
Christopher J. Ball 2 February 2024 0 0 118,144
Jason E. Doughty 31 January 2024 344,647 0 0
Jason E. Doughty 1 February 2024 0 0 66,616
Jason E. Doughty 2 February 2024 0 0 69,025
Ronald W. Glass 31 January 2024 85,000 50,000 0
Ronald W. Glass 1 February 2024 0 0 17,525
Ronald W. Glass 2 February 2024 0 0 18,115
Andrew G. Inglis 31 January 2024 837,500 270,600 0
Andrew G. Inglis 1 February 2024 0 0 166,524
Andrew G. Inglis 2 February 2024 0 0 171,941
Neal D. Shah 31 January 2024 423,000 148,500 0
Neal D. Shah 1 February 2024 0 0 84,672
Neal D. Shah 2 February 2024 0 0 87,655
The Notification of Dealing Form for each PDMR, which provides full details of
the transactions outlined above, can be found below.
This notification is made in accordance with Article 19 of the EU Market Abuse
Regulation.
Josh R. Marion
Assistant Secretary
CONTACT:
Investor Relations
Jamie Buckland
+44 203 954 2831
jbuckland@kosmosenergy.com
Media Relations
Thomas Golembeski
+1-214-445-9674
tgolembeski@kosmosenergy.com
1. Details of PDMR / person closely associated with them ("PCA")
a) Name Christopher J. Ball
b) Position / status SVP and Chief Commercial Officer
c) Initial notification / amendment Initial notification
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions (1) 493,000 shares issued on settlement of restricted share units granted
to the reporting person on 31 January 2021 under the Company's Long Term
Incentive Plan (the "Plan") based on the target level of achievement of the
applicable performance condition.
(2) 99,525 restricted share units granted under the Plan which are
scheduled to vest with respect to one-third of the total number of shares on
January 31 of each of 2025, 2026 and 2027, subject to the terms of the Plan
and the applicable award agreement issued thereunder.
Shares Granted or Vested
c) Currency USD
Price 6.06
Volume 592,525
Total 3,590,701.50
Shares sold or withheld
d) Currency USD
Price 0
Volume 0
Total 0
e) Aggregated information
Price 6.06
Volume 592,525
Total 3,590,701.50
f) Date of the transactions 31 January 2024
g) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 114,423 shares sold to satisfy the tax withholding requirement arising from
the vesting of restricted shares granted to the reporting person under the
Plan.
Shares Granted or Vested
c) Currency USD
Price 0
Volume 0
Total 0
Shares sold or withheld
d) Currency USD
Price 6.0287
Volume 114,423
Total 689,821.94
e) Aggregated information
Price 6.0287
Volume 114,423
Total 689,821.94
f) Date of the transactions 1 February 2024
g) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 118,144 shares sold to satisfy the tax withholding requirement arising from
the vesting of restricted shares granted to the reporting person under the
Plan.
Shares Granted or Vested
c) Currency USD
Price 0
Volume 0
Total 0
Shares sold or withheld
d) Currency USD
Price 5.8388
Volume 118,144
Total 689,819.19
e) Aggregated information
Price 5.8388
Volume 118,144
Total 689,819.19
f) Date of the transactions 2 February 2024
g) Place of the transaction NYSE
1. Details of PDMR / person closely associated with them ("PCA")
a) Name Jason E. Doughty
b) Position / status SVP and General Counsel
c) Initial notification / amendment Initial notification
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 344,647 shares issued on settlement of restricted share units granted to the
reporting person on 31 January 2021 under the Company's Long Term Incentive
Plan (the "Plan") based on the target level of achievement of the applicable
performance condition.
Shares Granted or Vested
c) Currency USD
Price 6.06
Volume 344,647
Total 2,088,560.82
Shares sold or withheld
d) Currency USD
Price 0
Volume 0
Total 0
e) Aggregated information
Price 6.06
Volume 344,647
Total 2,088,560.82
f) Date of the transactions 31 January 2024
g) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 66,616 shares sold to satisfy the tax withholding requirement arising from the
vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c) Currency USD
Price 0
Volume 0
Total 0
Shares sold or withheld
d) Currency USD
Price 6.0287
Volume 66,616
Total 401,607.88
e) Aggregated information
Price 6.0287
Volume 66,616
Total 401,607.88
f) Date of the transactions 1 February 2024
g) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 69,025 shares sold to satisfy the tax withholding requirement arising from the
vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c) Currency USD
Price 0
Volume 0
Total 0
Shares sold or withheld
d) Currency USD
Price 5.8388
Volume 69,025
Total 403,023.17
e) Aggregated information
Price 5.8388
Volume 69,025
Total 403,023.17
f) Date of the transactions 2 February 2024
g) Place of the transaction NYSE
1. Details of PDMR / person closely associated with them ("PCA")
a) Name Ronald W. Glass
b) Position / status Vice President and Chief Accounting Officer
c) Initial notification / amendment Initial notification
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions (1) 85,000 shares issued on settlement of restricted share units granted
to the reporting person on 31 January 2021 under the Company's Long Term
Incentive Plan (the "Plan") based on the target level of achievement of the
applicable performance condition.
(2) 50,000 restricted share units granted under the Plan which are
scheduled to vest with respect to one-third of the total number of shares on
January 31 of each of 2025, 2026 and 2027, subject to the terms of the Plan
and the applicable award agreement issued thereunder.
Shares Granted or Vested
c) Currency USD
Price 6.06
Volume 135,000
Total 818,100
Shares sold or withheld
d) Currency USD
Price 0
Volume 0
Total 0
e) Aggregated information
Price 6.06
Volume 135,000
Total 818,100
f) Date of the transactions 31 January 2024
g) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 17,525 shares sold to satisfy the tax withholding requirement arising from the
vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c) Currency USD
Price 0
Volume 0
Total 0
Shares sold or withheld
d) Currency USD
Price 6.0287
Volume 17,525
Total 105,652.97
e) Aggregated information
Price 6.0287
Volume 17,525
Total 105,652.97
f) Date of the transactions 1 February 2024
g) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 18,115 shares sold to satisfy the tax withholding requirement arising from the
vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c) Currency USD
Price 0
Volume 0
Total 0
Shares sold or withheld
d) Currency USD
Price 5.8388
Volume 18,115
Total 105,769.86
e) Aggregated information
Price 5.8388
Volume 18,115
Total 105,769.86
f) Date of the transactions 2 February 2024
g) Place of the transaction NYSE
1. Details of PDMR / person closely associated with them ("PCA")
a) Name Andrew G. Inglis
b) Position / status Chairman and Chief Executive Officer
c) Initial notification / amendment Initial notification
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions (1) 837,500 shares issued on settlement of restricted share units granted
to the reporting person on 31 January 2021 under the Company's Long Term
Incentive Plan (the "Plan") based on the target level of achievement of the
applicable performance condition.
(2) 270,600 restricted share units granted under the Plan which are
scheduled to vest with respect to one-third of the total number of shares on
January 31 of each of 2025, 2026 and 2027, subject to the terms of the Plan
and the applicable award agreement issued thereunder.
Shares Granted or Vested
c) Currency USD
Price 6.06
Volume 1,108,100
Total 6,715,086
Shares sold or withheld
d) Currency USD
Price 0
Volume 0
Total 0
e) Aggregated information
Price 6.06
Volume 1,108,100
Total 6,715,086
f) Date of the transactions 31 January 2024
g) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 166,524 shares sold to satisfy the tax withholding requirement arising from
the vesting of restricted shares granted to the reporting person under the
Plan.
Shares Granted or Vested
c) Currency USD
Price 0
Volume 0
Total 0
Shares sold or withheld
d) Currency USD
Price 6.0287
Volume 166,524
Total 1,003,923.24
e) Aggregated information
Price 6.0287
Volume 166,524
Total 1,003,923.24
f) Date of the transactions 1 February 2024
g) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 171,941 shares sold to satisfy the tax withholding requirement arising from
the vesting of restricted shares granted to the reporting person under the
Plan.
Shares Granted or Vested
c) Currency USD
Price 0
Volume 0
Total 0
Shares sold or withheld
d) Currency USD
Price 5.8388
Volume 171,941
Total 1,003,929.11
e) Aggregated information
Price 5.8388
Volume 171,941
Total 1,003,929.11
f) Date of the transactions 2 February 2024
g) Place of the transaction NYSE
1. Details of PDMR / person closely associated with them ("PCA")
a) Name Neal D. Shah
b) Position / status Senior Vice President and Chief Financial Officer
c) Initial notification / amendment Initial notification
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions (1) 423,000 shares issued on settlement of restricted share units granted
to the reporting person on 31 January 2021 under the Company's Long Term
Incentive Plan (the "Plan") based on the target level of achievement of the
applicable performance condition.
(2) 148,500 restricted share units granted under the Plan which are
scheduled to vest with respect to one-third of the total number of shares on
January 31 of each of 2025, 2026 and 2027, subject to the terms of the Plan
and the applicable award agreement issued thereunder.
Shares Granted or Vested
c) Currency USD
Price 6.06
Volume 571,500
Total 3,463,290
Shares sold or withheld
d) Currency USD
Price 0
Volume 0
Total 0
e) Aggregated information
Price 6.06
Volume 571,500
Total 3,463,290
f) Date of the transactions 31 January 2024
g) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 84,672 shares sold to satisfy the tax withholding requirement arising from the
vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c) Currency USD
Price 0
Volume 0
Total 0
Shares sold or withheld
d) Currency USD
Price 6.0287
Volume 84,672
Total 510,462.09
e) Aggregated information
Price 6.0287
Volume 84,672
Total 510,462.09
f) Date of the transactions 1 February 2024
g) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 87,655 shares sold to satisfy the tax withholding requirement arising from the
vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c) Currency USD
Price 0
Volume 0
Total 0
Shares sold or withheld
d) Currency USD
Price 5.8388
Volume 87,655
Total 511,800.01
e) Aggregated information
Price 5.8388
Volume 87,655
Total 511,800.01
f) Date of the transactions 2 February 2024
g) Place of the transaction NYSE
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHSSEFILELSELE